Categories AlphaGraphs, Consumer, Earnings
Infographic: Key highlights from Altria’s (MO) Q4 2023 earnings results
Altria Group, Inc. (NYSE: MO) reported fourth quarter 2023 earnings results today.
Net revenues decreased 2.2% year-over-year to $5.97 billion. Revenues, net of excise taxes, fell 1.2% to $5 billion.
Net earnings declined 23.4% to $2 billion and EPS dropped 22.7% to $1.16. Adjusted EPS remained flat at $1.18.
Revenue and earnings both beat estimates.
For the full year of 2024, the company expects adjusted EPS to range between $5.00-5.15.
The stock was up over 2% in morning trade on Thursday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key takeaways from JM Smucker’s (SJM) Q4 2025 earnings report
Shares of The J.M. Smucker Co. (NYSE: SJM) plunged 15% on Tuesday after the company delivered mixed results for the fourth quarter of 2025. While earnings came ahead of expectations,
J.M. Smucker (SJM) Q4 2025 Earnings: Key financials and quarterly highlights
The J.M. Smucker Co. (NYSE: SJM) reported its fourth quarter 2025 earnings results today. Net sales was $2.1 billion, down 3% year-over-year. Comparable net sales decreased 1%. Net loss was
Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials
Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing a pipeline of product candidates with lead programs
